|
|
|
|
| TRADING CENTER |
55.38-0.07 / -0.13%
Cephalon Inc (NASDAQ GS:CEPH)
55.36-0.02 / -0.04
After hours quote
Prev. Close:
55.45
Open:
55.99
High:
56.25
Low:
54.87
Volume:
1,959,600
Volume Avg.:
2,400,700
52wk Range:
52.55 - 81.35
Market Cap (mil):
4,134.62
P/E Ratio:
15.38
Dividend Yield:
N/A
| Cephalon Sues Teva - Analyst Blog - Zacks.com | |
| Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals - PR Newswire | |
| These Growth Stocks Are Also Good Values - MotleyFool.com | |
| Cephalon Settles Barr Challenge - Analyst Blog - Zacks.com | |
| Cephalon stock drops after trial data disappoint - Reuters | |
| Cephalon stock drops after mixed drug trial data - Reuters | |
| A Big Upgrade for Allos Therapeutics - MotleyFool.com | |
| Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of... - PR Newswire | |
| Cephalon, Barr settle patent infringement suit - Reuters | |
| Daily Blogwatch: The worst idea for a bad economy! - DailyFinance | |
| Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable... - PR Newswire | |
 Bad news Boeing - CNNMoney.com | |
| Merck $4.8B settlement nears - CNNMoney.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.36 | 0.20 / 0.31% | 14.05 |
| PFE | Pfizer Inc | 18.49 | -0.15 / -0.80% | 15.54 |
| NVS | Novartis AG | 55.55 | -0.23 / -0.41% | 15.60 |
Short Interest Date:
Nov 13 2009
Short Interest Shares:
7,874,846
Short Interest Ratio:
3.4
Float:
74,158,281
Short Interest as a % of Float:
16.0%
Average Daily Volume:
2,009,000
Outstanding Shares:
74,658,665
Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in three core therapeutic areas: central nervous system, pain, and oncology. In addition to conducting an active research and development program, it ... (more)
| 2008 Revenue: | $2.0 B | Headquarters: Frazer, PA |
| Employees: | 2,780 | CEO: Dr. Frank Baldino, Jr., Ph.D. |
| Net Income: | $222.5 M | Industry: Pharmaceuticals |
| Market Cap: | $4.1 B | Website: www.cephalon.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| CEPH | 55.38 | -0.07 / -0.13% | 55.45 | 56.25 | 54.87 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
